Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

PLoS One · 2021 · PMC8216517 · PMID 34153064

Europe PMC DOI

hedged sentence

0.1490

closest p · 3.0× alpha

0.1490

boldest claim

The sentences

did not reach statistical significancep = 0.149not close (p > 0.1)

IDH1/2 MRD negativity (VAF<0.2%) before allo-HSCT did not reach statistical significance (24-month OS MRD neg : 92.3±7.4% versus MRD pos 68.6±18.6%, p = 0.149).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.